Ads
related to: hodgkin vs non lymphoma prognosis- Patient Characteristics
See Which Patient Types Are Fit
For This FDA-Approved Treatment
- View Dosing Information
Access The Dosing Schedule
& Administration Info
- Efficacy & Safety Data
Review The Clinical Trial Results
Including Subgroup Analyses
- Register for Updates
Stay Informed About The Latest
Clinical Data Updates & More
- Patient Characteristics
Search results
Results From The WOW.Com Content Network
Non-Hodgkin lymphoma (NHL), also known as non-Hodgkin's lymphoma, is a group of blood cancers that includes all types of lymphomas except Hodgkin lymphomas. [1] Symptoms include enlarged lymph nodes, fever, night sweats, weight loss, and tiredness. [1] Other symptoms may include bone pain, chest pain, or itchiness. [1]
The authors concluded that trials using a patient mix weighted toward good prognosis will not find such a difference. In 1993, a retrospective analysis was performed on 2031 patients with aggressive non-Hodgkin's lymphoma, of all ages, treated with a doxorubicin-based chemotherapy regimen such as CHOP between 1982 and 1987. [2]
Non-Hodgkin lymphomas, which are defined as being all lymphomas except Hodgkin lymphoma, are more common than Hodgkin lymphoma. A wide variety of lymphomas are in this class, and the causes, the types of cells involved, and the prognoses vary by type. The number of cases per year of non-Hodgkin lymphoma increases with age.
What is non-Hodgkin lymphoma? Non-Hodgkin lymphoma (sometimes simply called NHL) is a form of blood cancer that strikes the white blood cells of the infection-fighting lymphatic system.
This type of Hodgkin lymphoma is most commonly seen in immunocompromised people. C81.2: M9652/3. Lymphocyte-rich: Is a rare subtype, shows many features which may cause diagnostic confusion with nodular lymphocyte predominant B-cell non-Hodgkin lymphoma (B-NHL). This form also has the most favorable prognosis. C81.0: M9651/3: Lymphocyte depleted
Score X: New areas of uptake unlikely to be related to lymphoma; Scores of 1 and 2 are considered to be negative and 4 and 5 are considered to be positive. "Score 3 should be interpreted according to the clinical context but in many Hodgkin Lymphoma patients indicates a good prognosis with standard treatment." [2]
Ads
related to: hodgkin vs non lymphoma prognosis